Greiner Bio-One News November 2022
Greiner Bio-One News brings you the latest content, product updates and other news directly to your inbox. A summary of articles in our latest edition are below and you can sign-up to future editions at the bottom of this page. Enjoy!
Ethical, scientific and financial concerns have led to the increasing importance of cell-based assays and three-dimensional cell culture in lieu of live-animal experimentation. Therefore, cell culture devices have been developed that allow the establishment of an in vitro environment with maximum retention of native functionality.
With respect to these developments, ThinCert® cell culture inserts with porous PET membranes are significant because they form a two-compartment system to readily mimic a variety of in vivo situations. Read more about ThinCert® in our new Forum ‘Innovative Solutions for Cell-Based Assays & Tissue Culture.’
Comparable results in blood collection are not only a question of material and collection technique - short-term changeable influencing factors should not be underestimated.
We are delighted to have been awarded a silver medal by EcoVadis for our sustainability commitment! For the first time our sustainability efforts have been evaluated across the entire group resulting in us being among the top 8% in our industry.
Greiner Bio-One in the UK is delighted to be partnering with Forest Green Rovers, described by FIFA as “The World’s Greenest Football Club.” Forest Green also became the first football club in the world to become 100% vegan (accredited by the vegan society) and in 2018 were recognised by the United Nations, receiving a “Momentum for Change” climate action award after becoming the first football club in the world to work with the UN to go carbon neutral.
What is MAPA and why should we pay attention to it? This is what we are discussing with our guest Winnie Cheche in the latest edition of Greiner Talks.
We are delighted to introduce the VACUETTE® EVOPROTECT SAFETY Blood Collection Set. The ground-breaking safety product meets the rigorous requirements of the EU Directive 2010/32. An innovative safety mechanism that can be conveniently activated while the needle is in the vein protects healthcare staff against potential injuries.
